Intranasal Photobiomodulation as a Potential Treatment for Parkinson’s Disease: A Randomized Placebo-Controlled Pilot Study
Photobiomodulation, Photomedicine, and Laser Surgery · 13.11.2026
DOI: 10.1177/25785478261508034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Photobiomodulation, Photomedicine, and Laser Surgery, online erschienen am 13.11.2026. Verfasst von Ana Maria Gois und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of São Paulo, São Carlos Institute Physics, São Carlos, Brazil. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a rapidly growing neurological disorder characterized by motor and non-motor symptoms associated with mitochondrial dysfunction and oxidative stress. Photobiomodulation (PBM) may modulate mitochondrial pathways. This randomized, controlled, single-blind pilot trial investigated intranasal and transpalatal PBM, individually or combined, in 48 individuals with idiopathic PD allocated to TP + IN (intranasal + transpalatal PBM), IN (intranasal PBM), TP (transpalatal PBM), or Sham. Participants underwent 24 sessions over 12 weeks using near-infrared light (808 nm, 100 mW, 60 J, or 120 J per point). Outcomes were assessed at baseline (T1), 1 week after the intervention (T2), and 1-month follow-up (T3) using the Montreal Cognitive Assessment (MoCA) and Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). Forty participants completed the study. IN significantly improved MoCA and MDS-UPDRS scores, with benefits persisting at follow-up. Sham showed a decline in MoCA. These findings suggest that intranasal PBM may be a promising adjunctive therapy for PD; further studies are needed to elucidate mechanisms and optimize treatment protocols.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of São Paulo, São Carlos Institute Physics, São Carlos, Brazil.
- Department of Physiology, Neurophysiology Laboratory, Federal University of Sergipe, São Cristóvão, Brazil.
ORCID-Profile: Ana Maria Gois
Zitieren
APA
Gois, A. M., Gianini, C., Panhoca, V. H., Santos, H. F., Lins, L. C. R. F., & Bagnato, V. S. (2026). Intranasal Photobiomodulation as a Potential Treatment for Parkinson’s Disease: A Randomized Placebo-Controlled Pilot Study. Photobiomodulation, Photomedicine, and Laser Surgery. https://doi.org/10.1177/25785478261508034
Vancouver
Gois AM, Gianini C, Panhoca VH, Santos HF, Lins LCRF, Bagnato VS. Intranasal Photobiomodulation as a Potential Treatment for Parkinson’s Disease: A Randomized Placebo-Controlled Pilot Study. Photobiomodulation, Photomedicine, and Laser Surgery. 2026. doi:10.1177/25785478261508034
BibTeX
@article{Gois2026,
author = {Gois, Ana Maria and Gianini, Carolina and Panhoca, Vitor Hugo and Santos, Heitor Franco and Lins, Lívia Cristina Rodrigues Ferreira and Bagnato, Vanderlei Salvador},
title = {Intranasal Photobiomodulation as a Potential Treatment for Parkinson’s Disease: A Randomized Placebo-Controlled Pilot Study},
journal = {Photobiomodulation, Photomedicine, and Laser Surgery},
year = {2026},
doi = {10.1177/25785478261508034}
}
EUVIMED